法国首例2019冠状病毒病(COVID-19)病例:2020年1月的监测、调查与控制措施
2020年1月24日法国确认3例COVID-19病例,为欧洲首批病例,立即启动接触者追踪;截至2月12日,5名接触者评估为低风险、18名为中/高风险,无续发传播。早期强化监测有助于发现输入病例并防止二代传播。
要点
- 2020年1月24日法国确认3例COVID-19,为欧洲首批病例。
- 立即启动接触者追踪:5名低风险、18名中/高风险。
- 截至2月12日无续发传播,2例出院、1例持续咳嗽。
核心结论
- 需要所有相关方有效协作以早期发现输入病例并实施 adequate 控制措施。
研究设计与样本
- 描述法国2020年1月COVID-19首批病例的监测、调查与控制措施。
- 法国于2020年1月10日实施强化监测以早期识别输入病例并防止二代传播。
- 定义了3类风险暴露和接触者随访程序。
- 2020年1月24日确认3例COVID-19,为欧洲首批病例。
主要发现
- 截至2020年2月12日,全球25个国家确诊45179例,包括1116例死亡。
- 接触者追踪立即启动,截至评估时5名接触者为低暴露风险、18名为中/高风险。
- 截至2020年2月12日,2例已出院,第3例仍有症状伴持续咳嗽,未发现续发传播。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A novel coronavirus (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2) causing a cluster of respiratory infections (coronavirus disease 2019, COVID-19) in Wuhan, China, was identified on 7 January 2020. The epidemic quickly disseminated from Wuhan and as at 12 February 2020, 45,179 cases have been confirmed in 25 countries, including 1,116 deaths. Strengthened surveillance was implemented in France on 10 January 2020 in order to identify imported cases early and prevent secondary transmission. Three categories of risk exposure and follow-up procedure were defined for contacts. Three cases of COVID-19 were confirmed on 24 January, the first cases in Europe. Contact tracing was immediately initiated. Five contacts were evaluated as at low risk of exposure and 18 at moderate/high risk. As at 12 February 2020, two cases have been discharged and the third one remains symptomatic with a persistent cough, and no secondary transmission has been identified. Effective collaboration between all parties involved in the surveillance and response to emerging threats is required to detect imported cases early and to implement adequate control measures.
引用
- Bernard Stoecklin S, Rolland P, Silue Y, et al. First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020. Euro Surveill. 2020. PMID: 32070465. doi:10.2807/1560-7917.ES.2020.25.6.2000094
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。